Realm Therapeutics
Malvern
About Realm Therapeutics
Realm Therapeutics is a biopharmaceutical company passionately committed to leveraging its proprietary technologies to protect and improve the health of adults and children. The Company's drug development focus, utilizing its immunomodulatory formulations, is targeted initially on developing small molecule therapies in inflammatory diseases with potential application in dermatology and ophthalmology, and the potential for broad applicability across a number of other diseases.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $26.0M
- Funding stage: M&A
- Last round: Post-IPO Equity (Sep 2017)
- Ticker: lse:RLM
- Website: realmtx.com
- Phone: (484)321-2700
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/realm-therapeutics-2244724 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.